Patients whose private data may have been stolen by a cyberprowler last December have filed a class action lawsuit against the radiology practice whose IT systems may have been hacked.  

The FDA has been busy this month. Review some of the biggest FDA-related stories of October, including big news from scPharmaceuticals, Abiomed, Bristol Myers Squibb and MedAlliance, in our monthly roundup. 

CMS stated the code would have an assigned payment rate of $900-$1,000. It became effective starting on October 1, 2022. 

The new guidance document was designed to help cardiologists and other clinicians deliver the best care possible when treating ASCVD patients who present with additional conditions that need to be considered. 

Patients impacted by this recall are advised to speak with a physician about how to proceed. 

The U.S. Food and Drug Administration granted Philips 510(k) clearance for its AI-powered MRI platform tailored to the treatment of head and neck cancers. 

A jury in Georgia has pinned 60% of the blame for a stroke patient’s permanent whole-body paralysis on an ER physician and 40% on a radiologist—while clearing all other clinicians who had a hand in the catastrophic episode of care.

Suggesting that the standard 10-year age gap screening rule might not be as beneficial as previously assumed, researchers have indicated that women with relatives diagnosed at younger ages should consider different screening criteria.